QA: Cambrex CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2019_Cambrex_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000820081, Cambrex CORP

  xvar xval
0 AssetsCurrent 410,092,000
1 IntangibleAssetsNetIncludingGoodwill 448,300,000
2 PropertyPlantAndEquipmentNet 360,528,000
3 remainder_Assets 4,508,000
4 LiabilitiesCurrent 104,412,000
5 LiabilitiesNoncurrent 65,795,000
6 remainder_Liabilities 399,494,000
7 CostOfGoodsAndServicesSold 335,405,000
8 SellingGeneralAndAdministrativeExpense 68,162,531
9 ResearchAndDevelopmentExpense 15,637,128
10 remainder_Expenses 61,416,741
11 remainder_Revenues 531,591,901
12 remainder_NetIncome 8,519,623
13 remainder_ComprehensiveNetIncome 23,181,118
  yvar yval
0 Assets 1,223,428,000
1 Liabilities 569,701,000
2 Expenses 480,621,400
3 Revenues 531,591,901
4 StockholdersEquity 653,727,000
5 NetIncome 59,490,124
6 ComprehensiveNetIncome 71,080,683
7 BaseVar 1,418,521,521
8 EconomicCapitalRatiobeforeLimitedLiability 1.67
9 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time